Finance · Search · Sign in · Sign up

Angelique buys ESRX 70.61: Cleveland Research's Rating Change Only Had Short-term Impact, Express Scripts Up 1.0% (ESRX)


One week ago Express Scripts (NASDAQ:ESRX) was downgraded from Buy to Neutral at Cleveland Research. The stock closed at $67.28, which is 1.0% higher than the price one week ago ($66.64). Express Scripts, Inc is a full service pharmacy benefit management . ... ...


62 people liked this



See more

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home